Ethiopian-American Scientist Uses Molecular Imaging for Early Detection of Heart Disease
New YorkÃ‚Â (TADIAS) Ã¢â‚¬â€œ In Spring 2009, weÃ‚Â featuredÃ‚Â Dr. Yared TekabeÃ¢â‚¬â„¢s groundbreaking work on non-invasive atherosclerosis detection and molecular imaging, which was published in the American Heart AssociationÃ‚Â´s journal,Ã‚Â Circulation. As in most chronic heart disease conditions, the plaque that accumulates in blood vessels is usually not detected until it leads to serious, and often fatal, blockages of blood supply such as during an episode of heart attack or stroke. Having received a $1.6 million grant from the National Institute of Health TekabeÃ¢â‚¬â„¢s research focused on the use of novel molecular imaging techniques to identify sites of inflammation that can help us with early detection of atherosclerosis.
In 2010, his work was highlighted in Osborn & JafferÃ¢â‚¬â„¢s review entitled Ã¢â‚¬Å“The Year in Molecular Imaging,Ã¢â‚¬Â noting that Tekabe and colleagues had developed a tracer that imaged RAGE Ã¢â‚¬â€ a receptor for advanced glycation end products, which is implicated in a host of inflammation-related diseases including artherosclerosis, cancer, diabetes and alzheimerÃ¢â‚¬â„¢s. TekabeÃ¢â‚¬â„¢s group, along with his colleague Dr. Ann Marie Schmidt, holds a patent for this RAGE-directed imaging technology.Ã‚Â More